SOURCES SOUGHT
A -- Vaccine and Treatment Evaluation Units (VTEUs): Evaluation of Control Measures Against Diseases Other Than AIDS
- Notice Date
- 5/15/2006
- Notice Type
- Sources Sought
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Office of Acquisitions 6700 B Rockledge Room 3214 MSC7612, Bethesda, MD, 20892-7612
- ZIP Code
- 20892-7612
- Solicitation Number
- NIH-NIAID-DMID-08-03
- Response Due
- 12/15/2006
- Description
- THIS NOTICE IS FOR INFORMATION AND PLANNING PURPOSES ONLY. THIS IS NOT A REQUEST FOR PROPOSALS AND DOES NOT COMMIT THE GOVERNMENT TO AWARD A CONTRACT NOW OR IN THE FUTURE. No solicitation is available at this time. The NAICS code is 541710 with a size standard of 500 employees. The Division of Microbiology and Infectious Diseases (DMID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), is seeking small businesses with the capabilities to evaluate vaccine and therapeutic candidates in Phase 1 through Phase 4 clinical trials, as well as to conduct other types of evaluations and analyses, for viral (other than HIV), bacterial, parasitic and fungal pathogens, including NIAID priority biodefense pathogens (http://www3.niaid.nih.gov/Biodefense/bandc_priority.htm). The scope of investigational vaccine and therapeutic candidates includes live, attenuated, killed, vectored DNA and combination vaccines, adjuvants, novel therapeutic agents such as immunomodulatory agents, and approaches to vaccine or therapeutic delivery, dose finding, schedule, routes and modes of delivery. The Contractor shall incorporate novel vaccine and therapeutic technologies as they are developed into clinical trials. Clinical research will be carried out in the general population, including pediatric, adult and elderly subjects, as well as additional populations, when necessary, such as women of reproductive age, pregnant women, immunocompromised populations, non-U.S. populations, and populations with underlying medical conditions. Contractors shall be experienced clinical research sites with access to general and additional study populations and the capacity to provide research facilities, services and personnel to carry out the full range of clinical research activities. These activities require outpatient and inpatient clinical research facilities, clinical and research laboratory facilities, research pharmacy facilities, and other general, non-clinical facilities. Scientific and technical staff shall have expertise, training and experience in the conduct and oversight of clinical trials and clinical studies in infectious diseases in accordance with Good Clinical Practices and applicable Federal regulations governing research involving human subjects. The complete Statement of Work and Technical Evaluation Criteria for this project are attached as separate PDF files. It is estimated that approximately 14-16 FTEs will be required annually for the performance of this project over a seven (7)-year period of performance. Small business concerns within this size standard that believe they possess the capability necessary to successfully undertake the work described in the Statement of Work should submit an original and three (3) copies of their capability statement tailored to this requirement to the address shown. Respondents may also submit their capability statements via e-mail or fax. Capability statements must identify the business status of the organization (i.e. small business, 8 (a), HUBZone, Service Disabled Veterans, etc.). No collect calls will be accepted. See Government Wide Numbered Notes 25 and 26.
- Record
- SN01048043-W 20060517/060515220230 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |